Corbus Pharmaceuticals Holdings, Inc. Repayments of Short-term Debt
Corbus Pharmaceuticals Holdings, Inc. (CRBP) reported Repayments of Short-term Debt of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-09.
Financial Statements › Cash Flow › Financing Activities
us-gaap:RepaymentsOfShortTermDebt · last filed 2026-03-09
- Corbus Pharmaceuticals Holdings, Inc. repayments of short-term debt for the quarter ending 2025-12-31 was $0.00.
- Corbus Pharmaceuticals Holdings, Inc. repayments of short-term debt for the quarter ending 2025-09-30 was $0.00, a 100.00% decline year-over-year.
- Corbus Pharmaceuticals Holdings, Inc. repayments of short-term debt for the quarter ending 2025-06-30 was $0.00, a 100.00% decline year-over-year.
- Corbus Pharmaceuticals Holdings, Inc. repayments of short-term debt for the quarter ending 2025-03-31 was $0.00, a 100.00% decline year-over-year.
- Corbus Pharmaceuticals Holdings, Inc. repayments of short-term debt for fiscal 2025 was $0.00, a 100.00% decline from fiscal 2024.
- Corbus Pharmaceuticals Holdings, Inc. repayments of short-term debt for fiscal 2024 was $301.00K, a 29.34% decline from fiscal 2023.
- Corbus Pharmaceuticals Holdings, Inc. repayments of short-term debt for fiscal 2023 was $426.00K, a 50.86% decline from fiscal 2022.
- Corbus Pharmaceuticals Holdings, Inc. repayments of short-term debt for fiscal 2022 was $866.87K, a 6.45% decline from fiscal 2021.
| Period end | Repayments of Short-term Debt 3 month | Repayments of Short-term Debt 3 month as first filed | Repayments of Short-term Debt 6 month | Repayments of Short-term Debt 6 month as first filed | Repayments of Short-term Debt 9 month | Repayments of Short-term Debt 9 month as first filed | Repayments of Short-term Debt 12 month | Repayments of Short-term Debt 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | $0.00 derived: sum of 2 quarters · filed 2026-03-09 | $0.00 derived: sum of 3 quarters · filed 2026-03-09 | $0.00 10-K · filed 2026-03-09 | ||||
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $0.00 derived: sum of 2 quarters · filed 2025-11-12 | $0.00 10-Q · filed 2025-11-12 | $0.00 derived: sum of 4 quarters · filed 2026-03-09 | ||||
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | $0.00 10-Q · filed 2025-08-05 | $0.00 derived: sum of 3 quarters · filed 2026-03-09 | $77.00K derived: sum of 4 quarters · filed 2026-03-09 | ||||
| 2025-03-31 | $0.00 10-Q · filed 2025-05-06 | $0.00 derived: sum of 2 quarters · filed 2026-03-09 | $77.00K derived: sum of 3 quarters · filed 2026-03-09 | $190.00K derived: sum of 4 quarters · filed 2026-03-09 | ||||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | $77.00K derived: sum of 2 quarters · filed 2026-03-09 | $190.00K derived: sum of 3 quarters · filed 2026-03-09 | $301.00K 10-K · filed 2026-03-09 | ||||
| 2024-09-30 | $77.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $190.00K derived: sum of 2 quarters · filed 2025-11-12 | $301.00K 10-Q · filed 2025-11-12 | $374.00K derived: sum of 4 quarters · filed 2025-11-12 | ||||
| 2024-06-30 | $113.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | $224.00K 10-Q · filed 2025-08-05 | $297.00K derived: sum of 3 quarters · filed 2025-08-05 | $348.00K derived: sum of 4 quarters · filed 2025-08-05 | ||||
| 2024-03-31 | $111.00K 10-Q · filed 2025-05-06 | $110.85K 10-Q · filed 2024-05-07 | $184.00K derived: sum of 2 quarters · filed 2025-05-06 | $235.00K derived: sum of 3 quarters · filed 2025-05-06 | $386.93K derived: sum of 4 quarters · filed 2025-05-06 | |||
| 2023-12-31 | $73.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-11 | $124.00K derived: sum of 2 quarters · filed 2025-03-11 | $275.93K derived: sum of 3 quarters · filed 2025-03-11 | $426.00K 10-K · filed 2025-03-11 | $425.98K 10-K · filed 2024-03-12 | |||
| 2023-09-30 | $51.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $202.93K derived: sum of 2 quarters · filed 2024-11-07 | $353.00K 10-Q · filed 2024-11-07 | $353.32K 10-Q · filed 2023-11-07 | $451.93K derived: sum of 4 quarters · filed 2024-11-07 | |||
| 2023-06-30 | $151.93K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | $302.00K 10-Q · filed 2024-08-06 | $302.17K 10-Q · filed 2023-08-08 | $400.93K derived: sum of 3 quarters · filed 2024-08-06 | $511.63K derived: sum of 4 quarters · filed 2024-08-06 | |||
| 2023-03-31 | $150.07K 10-Q · filed 2024-05-07 | $248.99K derived: sum of 2 quarters · filed 2024-05-07 | $359.70K derived: sum of 3 quarters · filed 2024-05-07 | $689.81K derived: sum of 4 quarters · filed 2024-05-07 | ||||
| 2022-12-31 | $98.93K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-12 | $209.63K derived: sum of 2 quarters · filed 2024-03-12 | $539.74K derived: sum of 3 quarters · filed 2024-03-12 | $866.87K 10-K · filed 2024-03-12 | ||||
| 2022-09-30 | $110.70K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $440.81K derived: sum of 2 quarters · filed 2023-11-07 | $767.94K 10-Q · filed 2023-11-07 | $984.37K derived: sum of 4 quarters · filed 2023-11-07 | ||||
| 2022-06-30 | $330.11K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $657.23K 10-Q · filed 2023-08-08 | $873.67K derived: sum of 3 quarters · filed 2023-08-08 | $976.36K derived: sum of 4 quarters · filed 2023-08-08 | ||||
| 2022-03-31 | $327.13K 10-Q · filed 2023-05-09 | $543.56K derived: sum of 2 quarters · filed 2023-05-09 | $646.25K derived: sum of 3 quarters · filed 2023-05-09 | $951.84K derived: sum of 4 quarters · filed 2023-05-09 | ||||
| 2021-12-31 | $216.44K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-07 | $319.13K derived: sum of 2 quarters · filed 2023-03-07 | $624.72K derived: sum of 3 quarters · filed 2023-03-07 | $926.60K 10-K · filed 2023-03-07 | ||||
| 2021-09-30 | $102.69K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $408.28K derived: sum of 2 quarters · filed 2022-11-08 | $710.16K 10-Q · filed 2022-11-08 | $909.38K derived: sum of 4 quarters · filed 2022-11-08 | ||||
| 2021-06-30 | $305.58K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $607.47K 10-Q · filed 2022-08-09 | $806.68K derived: sum of 3 quarters · filed 2022-08-09 | $915.62K derived: sum of 4 quarters · filed 2022-08-09 | ||||
| 2021-03-31 | $301.88K 10-Q · filed 2022-05-10 | $501.10K derived: sum of 2 quarters · filed 2022-05-10 | $610.03K derived: sum of 3 quarters · filed 2022-05-10 | $934.00K derived: sum of 4 quarters · filed 2022-05-10 | ||||
| 2020-12-31 | $199.22K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-08 | $308.15K derived: sum of 2 quarters · filed 2022-03-08 | $632.12K derived: sum of 3 quarters · filed 2022-03-08 | $951.88K 10-K · filed 2022-03-08 | ||||
| 2020-09-30 | $108.94K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $432.90K derived: sum of 2 quarters · filed 2021-11-12 | $752.66K 10-Q · filed 2021-11-12 | |||||
| 2020-06-30 | $323.97K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $643.72K 10-Q · filed 2021-08-12 | ||||||
| 2020-03-31 | $319.75K 10-Q · filed 2021-05-13 | |||||||
| 2019-12-31 | $605.16K 10-K · filed 2021-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |